1 Market Overview of Cisplatin 1.1 Cisplatin Market Overview 1.1.1 Cisplatin Product Scope 1.1.2 Cisplatin Market Status and Outlook 1.2 Global Cisplatin Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Cisplatin Market Size by Region (2016-2027) 1.4 Global Cisplatin Historic Market Size by Region (2016-2021) 1.5 Global Cisplatin Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Cisplatin Market Size (2016-2027) 1.6.1 North America Cisplatin Market Size (2016-2027) 1.6.2 Europe Cisplatin Market Size (2016-2027) 1.6.3 Asia-Pacific Cisplatin Market Size (2016-2027) 1.6.4 Latin America Cisplatin Market Size (2016-2027) 1.6.5 Middle East & Africa Cisplatin Market Size (2016-2027) 2 Cisplatin Market Overview by Type 2.1 Global Cisplatin Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Cisplatin Historic Market Size by Type (2016-2021) 2.3 Global Cisplatin Forecasted Market Size by Type (2022-2027) 2.4 Tablets 2.5 Injection 3 Cisplatin Market Overview by Application 3.1 Global Cisplatin Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Cisplatin Historic Market Size by Application (2016-2021) 3.3 Global Cisplatin Forecasted Market Size by Application (2022-2027) 3.4 Testicular Cancer 3.5 Osteosarcoma 3.6 Breast Cancer 4 Cisplatin Competition Analysis by Players 4.1 Global Cisplatin Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cisplatin as of 2020) 4.3 Date of Key Players Enter into Cisplatin Market 4.4 Global Top Players Cisplatin Headquarters and Area Served 4.5 Key Players Cisplatin Product Solution and Service 4.6 Competitive Status 4.6.1 Cisplatin Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Eli Lilly and Company 5.1.1 Eli Lilly and Company Profile 5.1.2 Eli Lilly and Company Main Business 5.1.3 Eli Lilly and Company Cisplatin Products, Services and Solutions 5.1.4 Eli Lilly and Company Cisplatin Revenue (US$ Million) & (2016-2021) 5.1.5 Eli Lilly and Company Recent Developments 5.2 Hospira 5.2.1 Hospira Profile 5.2.2 Hospira Main Business 5.2.3 Hospira Cisplatin Products, Services and Solutions 5.2.4 Hospira Cisplatin Revenue (US$ Million) & (2016-2021) 5.2.5 Hospira Recent Developments 5.3 Pfizer 5.5.1 Pfizer Profile 5.3.2 Pfizer Main Business 5.3.3 Pfizer Cisplatin Products, Services and Solutions 5.3.4 Pfizer Cisplatin Revenue (US$ Million) & (2016-2021) 5.3.5 Bedford Pharmaceuticals Recent Developments 5.4 Bedford Pharmaceuticals 5.4.1 Bedford Pharmaceuticals Profile 5.4.2 Bedford Pharmaceuticals Main Business 5.4.3 Bedford Pharmaceuticals Cisplatin Products, Services and Solutions 5.4.4 Bedford Pharmaceuticals Cisplatin Revenue (US$ Million) & (2016-2021) 5.4.5 Bedford Pharmaceuticals Recent Developments 5.5 Alvogen 5.5.1 Alvogen Profile 5.5.2 Alvogen Main Business 5.5.3 Alvogen Cisplatin Products, Services and Solutions 5.5.4 Alvogen Cisplatin Revenue (US$ Million) & (2016-2021) 5.5.5 Alvogen Recent Developments 5.6 Athenex Pharmaceutical 5.6.1 Athenex Pharmaceutical Profile 5.6.2 Athenex Pharmaceutical Main Business 5.6.3 Athenex Pharmaceutical Cisplatin Products, Services and Solutions 5.6.4 Athenex Pharmaceutical Cisplatin Revenue (US$ Million) & (2016-2021) 5.6.5 Athenex Pharmaceutical Recent Developments 5.7 Gland Pharma (Fosun Pharma) 5.7.1 Gland Pharma (Fosun Pharma) Profile 5.7.2 Gland Pharma (Fosun Pharma) Main Business 5.7.3 Gland Pharma (Fosun Pharma) Cisplatin Products, Services and Solutions 5.7.4 Gland Pharma (Fosun Pharma) Cisplatin Revenue (US$ Million) & (2016-2021) 5.7.5 Gland Pharma (Fosun Pharma) Recent Developments 5.8 West-Ward Pharmaceuticals 5.8.1 West-Ward Pharmaceuticals Profile 5.8.2 West-Ward Pharmaceuticals Main Business 5.8.3 West-Ward Pharmaceuticals Cisplatin Products, Services and Solutions 5.8.4 West-Ward Pharmaceuticals Cisplatin Revenue (US$ Million) & (2016-2021) 5.8.5 West-Ward Pharmaceuticals Recent Developments 5.9 WG Critical Care 5.9.1 WG Critical Care Profile 5.9.2 WG Critical Care Main Business 5.9.3 WG Critical Care Cisplatin Products, Services and Solutions 5.9.4 WG Critical Care Cisplatin Revenue (US$ Million) & (2016-2021) 5.9.5 WG Critical Care Recent Developments 5.10 David Bull Laboratories 5.10.1 David Bull Laboratories Profile 5.10.2 David Bull Laboratories Main Business 5.10.3 David Bull Laboratories Cisplatin Products, Services and Solutions 5.10.4 David Bull Laboratories Cisplatin Revenue (US$ Million) & (2016-2021) 5.10.5 David Bull Laboratories Recent Developments 5.11 Omega Laboratories 5.11.1 Omega Laboratories Profile 5.11.2 Omega Laboratories Main Business 5.11.3 Omega Laboratories Cisplatin Products, Services and Solutions 5.11.4 Omega Laboratories Cisplatin Revenue (US$ Million) & (2016-2021) 5.11.5 Omega Laboratories Recent Developments 5.12 Fresenius Kabi 5.12.1 Fresenius Kabi Profile 5.12.2 Fresenius Kabi Main Business 5.12.3 Fresenius Kabi Cisplatin Products, Services and Solutions 5.12.4 Fresenius Kabi Cisplatin Revenue (US$ Million) & (2016-2021) 5.12.5 Fresenius Kabi Recent Developments 5.13 TEVA 5.13.1 TEVA Profile 5.13.2 TEVA Main Business 5.13.3 TEVA Cisplatin Products, Services and Solutions 5.13.4 TEVA Cisplatin Revenue (US$ Million) & (2016-2021) 5.13.5 TEVA Recent Developments 5.14 Mylan Pharmaceuticals 5.14.1 Mylan Pharmaceuticals Profile 5.14.2 Mylan Pharmaceuticals Main Business 5.14.3 Mylan Pharmaceuticals Cisplatin Products, Services and Solutions 5.14.4 Mylan Pharmaceuticals Cisplatin Revenue (US$ Million) & (2016-2021) 5.14.5 Mylan Pharmaceuticals Recent Developments 5.15 Yunnan Plant Pharmaceutical 5.15.1 Yunnan Plant Pharmaceutical Profile 5.15.2 Yunnan Plant Pharmaceutical Main Business 5.15.3 Yunnan Plant Pharmaceutical Cisplatin Products, Services and Solutions 5.15.4 Yunnan Plant Pharmaceutical Cisplatin Revenue (US$ Million) & (2016-2021) 5.15.5 Yunnan Plant Pharmaceutical Recent Developments 5.16 Yunnan Biological Valley Pharmaceutical 5.16.1 Yunnan Biological Valley Pharmaceutical Profile 5.16.2 Yunnan Biological Valley Pharmaceutical Main Business 5.16.3 Yunnan Biological Valley Pharmaceutical Cisplatin Products, Services and Solutions 5.16.4 Yunnan Biological Valley Pharmaceutical Cisplatin Revenue (US$ Million) & (2016-2021) 5.16.5 Yunnan Biological Valley Pharmaceutical Recent Developments 5.17 Dezhou de Pharmaceutical 5.17.1 Dezhou de Pharmaceutical Profile 5.17.2 Dezhou de Pharmaceutical Main Business 5.17.3 Dezhou de Pharmaceutical Cisplatin Products, Services and Solutions 5.17.4 Dezhou de Pharmaceutical Cisplatin Revenue (US$ Million) & (2016-2021) 5.17.5 Dezhou de Pharmaceutical Recent Developments 5.18 Jiangsu Haosen Pharmaceutical Group 5.18.1 Jiangsu Haosen Pharmaceutical Group Profile 5.18.2 Jiangsu Haosen Pharmaceutical Group Main Business 5.18.3 Jiangsu Haosen Pharmaceutical Group Cisplatin Products, Services and Solutions 5.18.4 Jiangsu Haosen Pharmaceutical Group Cisplatin Revenue (US$ Million) & (2016-2021) 5.18.5 Jiangsu Haosen Pharmaceutical Group Recent Developments 5.19 Qilu Pharmaceutical 5.19.1 Qilu Pharmaceutical Profile 5.19.2 Qilu Pharmaceutical Main Business 5.19.3 Qilu Pharmaceutical Cisplatin Products, Services and Solutions 5.19.4 Qilu Pharmaceutical Cisplatin Revenue (US$ Million) & (2016-2021) 5.19.5 Qilu Pharmaceutical Recent Developments 6 North America 6.1 North America Cisplatin Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Cisplatin Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Cisplatin Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Cisplatin Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Cisplatin Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Cisplatin Market Dynamics 11.1 Cisplatin Industry Trends 11.2 Cisplatin Market Drivers 11.3 Cisplatin Market Challenges 11.4 Cisplatin Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Cisplatin Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Cisplatin Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Cisplatin Market Size Share by Region (2016-2021) Table 4. Global Cisplatin Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Cisplatin Forecasted Market Size Share by Region (2022-2027) Table 6. Global Cisplatin Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Cisplatin Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Cisplatin Revenue Market Share by Type (2016-2021) Table 9. Global Cisplatin Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Cisplatin Revenue Market Share by Type (2022-2027) Table 11. Global Cisplatin Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Cisplatin Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Cisplatin Revenue Market Share by Application (2016-2021) Table 14. Global Cisplatin Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Cisplatin Revenue Market Share by Application (2022-2027) Table 16. Global Cisplatin Revenue (US$ Million) by Players (2016-2021) Table 17. Global Cisplatin Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cisplatin as of 2020) Table 19. Date of Key Manufacturers Enter into Cisplatin Market Table 20. Global Cisplatin Top Players Headquarters and Area Served Table 21. Cisplatin Product Solution and Service Table 22. Global Cisplatin Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Eli Lilly and Company Basic Information List Table 25. Eli Lilly and Company Description and Business Overview Table 26. Eli Lilly and Company Cisplatin Products, Services and Solutions Table 27. Revenue (US$ Million) in Cisplatin Business of Eli Lilly and Company (2016-2021) Table 28. Eli Lilly and Company Recent Developments Table 29. Hospira Basic Information List Table 30. Hospira Description and Business Overview Table 31. Hospira Cisplatin Products, Services and Solutions Table 32. Revenue (US$ Million) in Cisplatin Business of Hospira (2016-2021) Table 33. Hospira Recent Developments Table 34. Pfizer Basic Information List Table 35. Pfizer Description and Business Overview Table 36. Pfizer Cisplatin Products, Services and Solutions Table 37. Revenue (US$ Million) in Cisplatin Business of Pfizer (2016-2021) Table 38. Pfizer Recent Developments Table 39. Bedford Pharmaceuticals Basic Information List Table 40. Bedford Pharmaceuticals Description and Business Overview Table 41. Bedford Pharmaceuticals Cisplatin Products, Services and Solutions Table 42. Revenue (US$ Million) in Cisplatin Business of Bedford Pharmaceuticals (2016-2021) Table 43. Bedford Pharmaceuticals Recent Developments Table 44. Alvogen Basic Information List Table 45. Alvogen Description and Business Overview Table 46. Alvogen Cisplatin Products, Services and Solutions Table 47. Revenue (US$ Million) in Cisplatin Business of Alvogen (2016-2021) Table 48. Alvogen Recent Developments Table 49. Athenex Pharmaceutical Basic Information List Table 50. Athenex Pharmaceutical Description and Business Overview Table 51. Athenex Pharmaceutical Cisplatin Products, Services and Solutions Table 52. Revenue (US$ Million) in Cisplatin Business of Athenex Pharmaceutical (2016-2021) Table 53. Athenex Pharmaceutical Recent Developments Table 54. Gland Pharma (Fosun Pharma) Basic Information List Table 55. Gland Pharma (Fosun Pharma) Description and Business Overview Table 56. Gland Pharma (Fosun Pharma) Cisplatin Products, Services and Solutions Table 57. Revenue (US$ Million) in Cisplatin Business of Gland Pharma (Fosun Pharma) (2016-2021) Table 58. Gland Pharma (Fosun Pharma) Recent Developments Table 59. West-Ward Pharmaceuticals Basic Information List Table 60. West-Ward Pharmaceuticals Description and Business Overview Table 61. West-Ward Pharmaceuticals Cisplatin Products, Services and Solutions Table 62. Revenue (US$ Million) in Cisplatin Business of West-Ward Pharmaceuticals (2016-2021) Table 63. West-Ward Pharmaceuticals Recent Developments Table 64. WG Critical Care Basic Information List Table 65. WG Critical Care Description and Business Overview Table 66. WG Critical Care Cisplatin Products, Services and Solutions Table 67. Revenue (US$ Million) in Cisplatin Business of WG Critical Care (2016-2021) Table 68. WG Critical Care Recent Developments Table 69. David Bull Laboratories Basic Information List Table 70. David Bull Laboratories Description and Business Overview Table 71. David Bull Laboratories Cisplatin Products, Services and Solutions Table 72. Revenue (US$ Million) in Cisplatin Business of David Bull Laboratories (2016-2021) Table 73. David Bull Laboratories Recent Developments Table 74. Omega Laboratories Basic Information List Table 75. Omega Laboratories Description and Business Overview Table 76. Omega Laboratories Cisplatin Products, Services and Solutions Table 77. Revenue (US$ Million) in Cisplatin Business of Omega Laboratories (2016-2021) Table 78. Omega Laboratories Recent Developments Table 79. Fresenius Kabi Basic Information List Table 80. Fresenius Kabi Description and Business Overview Table 81. Fresenius Kabi Cisplatin Products, Services and Solutions Table 82. Revenue (US$ Million) in Cisplatin Business of Fresenius Kabi (2016-2021) Table 83. Fresenius Kabi Recent Developments Table 84. TEVA Basic Information List Table 85. TEVA Description and Business Overview Table 86. TEVA Cisplatin Products, Services and Solutions Table 87. Revenue (US$ Million) in Cisplatin Business of TEVA (2016-2021) Table 88. TEVA Recent Developments Table 89. Mylan Pharmaceuticals Basic Information List Table 90. Mylan Pharmaceuticals Description and Business Overview Table 91. Mylan Pharmaceuticals Cisplatin Products, Services and Solutions Table 92. Revenue (US$ Million) in Cisplatin Business of Mylan Pharmaceuticals (2016-2021) Table 93. Mylan Pharmaceuticals Recent Developments Table 94. Yunnan Plant Pharmaceutical Basic Information List Table 95. Yunnan Plant Pharmaceutical Description and Business Overview Table 96. Yunnan Plant Pharmaceutical Cisplatin Products, Services and Solutions Table 97. Revenue (US$ Million) in Cisplatin Business of Yunnan Plant Pharmaceutical (2016-2021) Table 98. Yunnan Plant Pharmaceutical Recent Developments Table 99. Yunnan Biological Valley Pharmaceutical Basic Information List Table 100. Yunnan Biological Valley Pharmaceutical Description and Business Overview Table 101. Yunnan Biological Valley Pharmaceutical Cisplatin Products, Services and Solutions Table 102. Revenue (US$ Million) in Cisplatin Business of Yunnan Biological Valley Pharmaceutical (2016-2021) Table 103. Yunnan Biological Valley Pharmaceutical Recent Developments Table 104. Dezhou de Pharmaceutical Basic Information List Table 105. Dezhou de Pharmaceutical Description and Business Overview Table 106. Dezhou de Pharmaceutical Cisplatin Products, Services and Solutions Table 107. Revenue (US$ Million) in Cisplatin Business of Dezhou de Pharmaceutical (2016-2021) Table 108. Dezhou de Pharmaceutical Recent Developments Table 109. Jiangsu Haosen Pharmaceutical Group Basic Information List Table 110. Jiangsu Haosen Pharmaceutical Group Description and Business Overview Table 111. Jiangsu Haosen Pharmaceutical Group Cisplatin Products, Services and Solutions Table 112. Revenue (US$ Million) in Cisplatin Business of Jiangsu Haosen Pharmaceutical Group (2016-2021) Table 113. Jiangsu Haosen Pharmaceutical Group Recent Developments Table 114. Qilu Pharmaceutical Basic Information List Table 115. Qilu Pharmaceutical Description and Business Overview Table 116. Qilu Pharmaceutical Cisplatin Products, Services and Solutions Table 117. Revenue (US$ Million) in Cisplatin Business of Qilu Pharmaceutical (2016-2021) Table 118. Qilu Pharmaceutical Recent Developments Table 119. North America Cisplatin Market Size by Country (2016-2021) & (US$ Million) Table 120. North America Cisplatin Market Size by Country (2022-2027) & (US$ Million) Table 121. Europe Cisplatin Market Size by Country (2016-2021) & (US$ Million) Table 122. Europe Cisplatin Market Size by Country (2022-2027) & (US$ Million) Table 123. Asia-Pacific Cisplatin Market Size by Region (2016-2021) & (US$ Million) Table 124. Asia-Pacific Cisplatin Market Size by Region (2022-2027) & (US$ Million) Table 125. Asia-Pacific Cisplatin Market Share by Region (2016-2021) Table 126. Asia-Pacific Cisplatin Market Share by Region (2022-2027) Table 127. Latin America Cisplatin Market Size by Country (2016-2021) & (US$ Million) Table 128. Latin America Cisplatin Market Size by Country (2022-2027) & (US$ Million) Table 129. Middle East & Africa Cisplatin Market Size by Players (2016-2021) & (US$ Million) Table 130. Middle East & Africa Cisplatin Market Size by Country (2022-2027) & (US$ Million) Table 131. Cisplatin Market Trends Table 132. Cisplatin Market Drivers Table 133. Cisplatin Market Challenges Table 134. Cisplatin Market Restraints Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Global Cisplatin Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Cisplatin Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Cisplatin Market Share by Regions: 2021 VS 2027 Figure 4. Global Cisplatin Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Cisplatin Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Cisplatin Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Cisplatin Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Cisplatin Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Cisplatin Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Cisplatin Market Size Share by Type in 2021 & 2027 Figure 11. Tablets Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Injection Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Global Cisplatin Market Size Share by Application in 2021 & 2027 Figure 14. Testicular Cancer Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Osteosarcoma Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Breast Cancer Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Cisplatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 18. Global Top 5 and Top 10 Players Cisplatin Market Share in 2020 Figure 19. North America Cisplatin Market Share by Country (2016-2027) Figure 20. United States Cisplatin Market Size (2016-2027) & (US$ Million) Figure 21. Canada Cisplatin Market Size (2016-2027) & (US$ Million) Figure 22. Germany Cisplatin Market Size (2016-2027) & (US$ Million) Figure 23. France Cisplatin Market Size (2016-2027) & (US$ Million) Figure 24. U.K. Cisplatin Market Size (2016-2027) & (US$ Million) Figure 25. Italy Cisplatin Market Size (2016-2027) & (US$ Million) Figure 26. Russia Cisplatin Market Size (2016-2027) & (US$ Million) Figure 27. Nordic Cisplatin Market Size (2016-2027) & (US$ Million) Figure 28. Rest of Europe Cisplatin Market Size (2016-2027) & (US$ Million) Figure 29. Asia-Pacific Cisplatin Market Share by Region (2016-2027) Figure 30. China Cisplatin Market Size (2016-2027) & (US$ Million) Figure 31. Japan Cisplatin Market Size (2016-2027) & (US$ Million) Figure 32. South Korea Cisplatin Market Size (2016-2027) & (US$ Million) Figure 33. Southeast Asia Cisplatin Market Size (2016-2027) & (US$ Million) Figure 34. India Cisplatin Market Size (2016-2027) & (US$ Million) Figure 35. Australia Cisplatin Market Size (2016-2027) & (US$ Million) Figure 36. Rest of Asia-Pacific Cisplatin Market Size (2016-2027) & (US$ Million) Figure 37. Latin America Cisplatin Market Share by Country (2016-2027) Figure 38. Mexico Cisplatin Market Size (2016-2027) & (US$ Million) Figure 39. Brazil Cisplatin Market Size (2016-2027) & (US$ Million) Figure 40. Rest of Latin America Cisplatin Market Size (2016-2027) & (US$ Million) Figure 41. Middle East & Africa Cisplatin Market Share by Country (2016-2027) Figure 42. Turkey Cisplatin Market Size (2016-2027) & (US$ Million) Figure 43. Saudi Arabia Cisplatin Market Size (2016-2027) & (US$ Million) Figure 44. UAE Cisplatin Market Size (2016-2027) & (US$ Million) Figure 45. Rest of Middle East & Africa Cisplatin Market Size (2016-2027) & (US$ Million) Figure 46. Bottom-up and Top-down Approaches for This Report Figure 47. Data Triangulation

Eli Lilly and Company Hospira Pfizer Bedford Pharmaceuticals Alvogen Athenex Pharmaceutical Gland Pharma (Fosun Pharma) West-Ward Pharmaceuticals WG Critical Care David Bull Laboratories Omega Laboratories Fresenius Kabi TEVA Mylan Pharmaceuticals Yunnan Plant Pharmaceutical Yunnan Biological Valley Pharmaceutical Dezhou de Pharmaceutical Jiangsu Haosen Pharmaceutical Group Qilu Pharmaceutical